ATL — Atlas Global Brands Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual income statement for Atlas Global Brands, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 15 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 5.8 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | -1.41 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.22 | 0.174 | 0.186 | 0.199 | 21.7 |
Operating Profit | -1.22 | -0.174 | -0.186 | -0.199 | -15.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.22 | -0.123 | -0.186 | -0.199 | -16.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.22 | -0.123 | -0.186 | -0.199 | -16.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.22 | -0.123 | -0.186 | -0.199 | -16.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.22 | -0.123 | -0.186 | -0.199 | -16.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.839 | -0.11 | -0.121 | -0.119 | -0.052 |
Dividends per Share |